PROMIS NEUROSCIENCES INC. Shareholders' Equity
PROMIS NEUROSCIENCES INC. (PMN) had Shareholders' Equity of $49.40 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $49.40M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $60.72M; Stockholders' Equity Attributable to Parent as first filed $60.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$1.26M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $9.19M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $49.40M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $60.72M 10-Q · filed 2026-08-13 | $60.72M 10-Q · filed 2026-05-12 |
| 2025-12-31 | -$1.26M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $9.19M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$382.58K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $9.47M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $16.49M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $7.27M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | -$2.28M 10-Q · filed 2025-11-12 | |
| 2024-03-31 | $77.10K 10-Q · filed 2025-08-13 | |
| 2023-12-31 | $3.75M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $6.75M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | -$8.53M 10-Q · filed 2024-11-14 | -$8.53M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$6.18M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | -$1.35M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $729.76K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $6.71M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $3.74M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $5.66M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $7.82M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$7.07M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | -$6.88M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | -$796.66K 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |